Evaluating the Performance of a Safe Insulin Supply Chain Using the AHP-TOPSIS Approach
<p dir="ltr">People with type 1 diabetes require insulin, a lifesaving and essential medication, to maintain their blood sugar levels below dangerous levels. Unfortunately, the insulin industry faces supply and affordability issues, and patients and their families face an enormous bu...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , |
| منشور في: |
2022
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1864513506618900480 |
|---|---|
| author | Mona Haji (18526764) |
| author2 | Laoucine Kerbache (17148370) Tareq Al-Ansari (9872268) |
| author2_role | author author |
| author_facet | Mona Haji (18526764) Laoucine Kerbache (17148370) Tareq Al-Ansari (9872268) |
| author_role | author |
| dc.creator.none.fl_str_mv | Mona Haji (18526764) Laoucine Kerbache (17148370) Tareq Al-Ansari (9872268) |
| dc.date.none.fl_str_mv | 2022-10-26T09:00:00Z |
| dc.identifier.none.fl_str_mv | 10.3390/pr10112203 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/journal_contribution/Evaluating_the_Performance_of_a_Safe_Insulin_Supply_Chain_Using_the_AHP-TOPSIS_Approach/26862475 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Biomedical and clinical sciences Medical biochemistry and metabolomics Pharmacology and pharmaceutical sciences Health sciences Public health pharmaceutical supply chain insulin safety drug counterfeit traceability technology |
| dc.title.none.fl_str_mv | Evaluating the Performance of a Safe Insulin Supply Chain Using the AHP-TOPSIS Approach |
| dc.type.none.fl_str_mv | Text Journal contribution info:eu-repo/semantics/publishedVersion text contribution to journal |
| description | <p dir="ltr">People with type 1 diabetes require insulin, a lifesaving and essential medication, to maintain their blood sugar levels below dangerous levels. Unfortunately, the insulin industry faces supply and affordability issues, and patients and their families face an enormous burden. As a result of high prices and lack of availability, individuals are turning to other options for purchasing insulin, such as online pharmacies, which may or may not be legitimate. Despite the necessity of safe insulin for diabetics in the legitimate Pharmaceutical Supply Chain (PSC), few researchers have considered implementing strategies to maximize patient safety for purchasing insulin. Therefore, the current research seeks to bridge this gap and provide cohesive information on overcoming this challenge and maximizing insulin safety. This study employs a Multi-Criteria Decision-Making (MCDM) model that combines Supply Chain Operations Reference (SCOR) metrics, Analytic Hierarchy Process (AHP), and Technique for Order of Preference by Similarity to Ideal Solution (TOPSIS) to develop a model that can prioritize and select the best criteria for maximizing insulin safety and achieving the study objective. A comparison of two insulin supply chain scenarios was performed. As a result of this research, adding a traceability technology to the insulin supply chain, specifically blockchain (T42) in scenario 2 provides the best results to the supply chain for maximizing and ensuring the safety of insulin, as compared to scenario 1, where the final score achieved almost 71%. This research provides a useful tool for assessing the safety of other critical goods that customers value in strategic and complex decision-making. Academics, professionals, and decision-makers can benefit from this research using a rigorous scientific decision-support system.</p><h2>Other Information</h2><p dir="ltr">Published in: Processes<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.3390/pr10112203" target="_blank">https://dx.doi.org/10.3390/pr10112203</a></p> |
| eu_rights_str_mv | openAccess |
| id | Manara2_b793625f24b868469a2e19ce93394688 |
| identifier_str_mv | 10.3390/pr10112203 |
| network_acronym_str | Manara2 |
| network_name_str | Manara2 |
| oai_identifier_str | oai:figshare.com:article/26862475 |
| publishDate | 2022 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Evaluating the Performance of a Safe Insulin Supply Chain Using the AHP-TOPSIS ApproachMona Haji (18526764)Laoucine Kerbache (17148370)Tareq Al-Ansari (9872268)Biomedical and clinical sciencesMedical biochemistry and metabolomicsPharmacology and pharmaceutical sciencesHealth sciencesPublic healthpharmaceutical supply chaininsulin safetydrug counterfeittraceability technology<p dir="ltr">People with type 1 diabetes require insulin, a lifesaving and essential medication, to maintain their blood sugar levels below dangerous levels. Unfortunately, the insulin industry faces supply and affordability issues, and patients and their families face an enormous burden. As a result of high prices and lack of availability, individuals are turning to other options for purchasing insulin, such as online pharmacies, which may or may not be legitimate. Despite the necessity of safe insulin for diabetics in the legitimate Pharmaceutical Supply Chain (PSC), few researchers have considered implementing strategies to maximize patient safety for purchasing insulin. Therefore, the current research seeks to bridge this gap and provide cohesive information on overcoming this challenge and maximizing insulin safety. This study employs a Multi-Criteria Decision-Making (MCDM) model that combines Supply Chain Operations Reference (SCOR) metrics, Analytic Hierarchy Process (AHP), and Technique for Order of Preference by Similarity to Ideal Solution (TOPSIS) to develop a model that can prioritize and select the best criteria for maximizing insulin safety and achieving the study objective. A comparison of two insulin supply chain scenarios was performed. As a result of this research, adding a traceability technology to the insulin supply chain, specifically blockchain (T42) in scenario 2 provides the best results to the supply chain for maximizing and ensuring the safety of insulin, as compared to scenario 1, where the final score achieved almost 71%. This research provides a useful tool for assessing the safety of other critical goods that customers value in strategic and complex decision-making. Academics, professionals, and decision-makers can benefit from this research using a rigorous scientific decision-support system.</p><h2>Other Information</h2><p dir="ltr">Published in: Processes<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.3390/pr10112203" target="_blank">https://dx.doi.org/10.3390/pr10112203</a></p>2022-10-26T09:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.3390/pr10112203https://figshare.com/articles/journal_contribution/Evaluating_the_Performance_of_a_Safe_Insulin_Supply_Chain_Using_the_AHP-TOPSIS_Approach/26862475CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/268624752022-10-26T09:00:00Z |
| spellingShingle | Evaluating the Performance of a Safe Insulin Supply Chain Using the AHP-TOPSIS Approach Mona Haji (18526764) Biomedical and clinical sciences Medical biochemistry and metabolomics Pharmacology and pharmaceutical sciences Health sciences Public health pharmaceutical supply chain insulin safety drug counterfeit traceability technology |
| status_str | publishedVersion |
| title | Evaluating the Performance of a Safe Insulin Supply Chain Using the AHP-TOPSIS Approach |
| title_full | Evaluating the Performance of a Safe Insulin Supply Chain Using the AHP-TOPSIS Approach |
| title_fullStr | Evaluating the Performance of a Safe Insulin Supply Chain Using the AHP-TOPSIS Approach |
| title_full_unstemmed | Evaluating the Performance of a Safe Insulin Supply Chain Using the AHP-TOPSIS Approach |
| title_short | Evaluating the Performance of a Safe Insulin Supply Chain Using the AHP-TOPSIS Approach |
| title_sort | Evaluating the Performance of a Safe Insulin Supply Chain Using the AHP-TOPSIS Approach |
| topic | Biomedical and clinical sciences Medical biochemistry and metabolomics Pharmacology and pharmaceutical sciences Health sciences Public health pharmaceutical supply chain insulin safety drug counterfeit traceability technology |